who should not use glp-1 Struggling with therapy side effects? You're alone. This Clinician Guide: Managing Common GLP-1 Receptor Agonist Side Effects provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects GLP-1 Safety Check - National

Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG

L-Carnitine tartrate (Standard) L-Carnitine (tartrate) (Standard) is the analytical standard of L-Carnitine (tartrate)

The trial enrolled 300 obese subjects (BMI 27-35 kg/m) across multiple centers and randomized them to AOD-9604 (3 mg subcutaneous injection once or twice daily) or placebo for 12 weeks

Daily Dose Your doctor will prescribe the correct dosage of NUROKIND LC INJECTION 5ML based on your specific medical condition, age, weight, and response to treatment

Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation